Choice-based HIV treatment support for adults in Cape Town
Part of Infections clinical trials.
This trial offers extra support for people who are starting or restarting HIV medication. It tests whether giving people a choice in their treatment support helps them stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Living with HIV
- Starting HIV medication for the first time or restarting after a break of at least three months
- Clinically stable (no serious illness like TB or meningitis right now)
- Speak English or isiXhosa
- Willing to take part and give permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with HIV who have had a gap in care (missed an appointment or had a detectable viral load). It tests a program to help you stay on your dolutegravir-based HIV medication and keep your viral load undetectable.
This study tests a new program for people living with HIV in South Africa who are struggling with food worries and emotional distress (like depression or trauma). It aims to help them take their HIV medicine more regularly and feel better overall.
This study tests a program to help people living with HIV who have missed their recent treatment appointment get back on track. It aims to find better ways to support ongoing treatment.
This study is testing a program to help people with HIV stick with their medication. It looks at how well doctors and patients work together to make treatment decisions and improve health outcomes.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This trial tests a counselling program called WeCare to help men who have sex with men in Johannesburg stick to their HIV or PrEP medication and manage depression symptoms. It is designed for those who are struggling with adherence or have unsuppressed HIV.
Hear when a new HIV Care Loss to Followup trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.